Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Motor Behavior and/or Learning in Children With Neurofibromatosis Type 1
NCT04481048Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Feb 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in neurofibromatosis type 1 (NF1), sponsored by Cincinnati Children's Hospital Medical Center. Started Feb 2021; status: completed.
02
Drugs
acetylcysteine
03
Conditions
neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on NCT04481048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04481048.